Abbott Laboratories (ABT) operating KPIs
ABTNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 28, 2026Score 14/3036% above fair value
$106.20+1.63 (+1.56%)
Close on Oct 30, 2026Market cap $183.77BP/E 34.1Yield 2.26%
Abbott Laboratories total Assets ($M) ($M)
Postgres DB financial_values + Form 10-K/10-Q XBRL
Latest, Q2 2026
109,215
Period ended Jun 30, 2026
Change on a year earlier
+30.0%
83,999 in Q2 2025
History
71 quarters
Since Q4 2007
Sources
66
Documents cited below
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Total Assets ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| Q2 2026 | Jun 30, 2026 | 109,215 | +30.0% | Form 10-Q (filed 2026-07-28) ↗ |
| Q1 2026 | Mar 31, 2026 | 110,429 | +35.6% | Form 10-Q (filed 2026-04-29) ↗ |
| Q4 2025 | Dec 31, 2025 | 86,713 | +6.5% | Form 10-K (filed 2026-02-20) ↗ |
| Q3 2025 | Sep 30, 2025 | 84,181 | +13.2% | Form 10-Q (filed 2025-10-29) ↗ |
| Q2 2025 | Jun 30, 2025 | 83,999 | +15.0% | Form 10-Q (filed 2025-07-30) ↗ |
| Q1 2025 | Mar 31, 2025 | 81,448 | +12.4% | Form 10-Q (filed 2025-04-30) ↗ |
| Q4 2024 | Dec 31, 2024 | 81,414 | +11.2% | Form 10-K (filed 2025-02-21) ↗ |
| Q3 2024 | Sep 30, 2024 | 74,356 | +3.1% | Form 10-Q (filed 2024-10-31) ↗ |
| Q2 2024 | Jun 30, 2024 | 73,017 | -0.5% | Form 10-Q (filed 2024-07-31) ↗ |
| Q1 2024 | Mar 31, 2024 | 72,467 | -1.8% | Form 10-Q (filed 2024-05-02) ↗ |
| Q4 2023 | Dec 31, 2023 | 73,214 | -1.6% | Form 10-K (filed 2024-02-16) ↗ |
| Q3 2023 | Sep 30, 2023 | 72,090 | -1.0% | Form 10-Q (filed 2023-11-01) ↗ |
| Q2 2023 | Jun 30, 2023 | 73,354 | -1.1% | Form 10-Q (filed 2023-08-03) ↗ |
| Q1 2023 | Mar 31, 2023 | 73,794 | -0.3% | Form 10-Q (filed 2023-05-04) ↗ |
| Q4 2022 | Dec 31, 2022 | 74,438 | -1.0% | Form 10-K (filed 2023-02-17) ↗ |
| Q3 2022 | Sep 30, 2022 | 72,801 | -1.3% | Form 10-Q (filed 2022-11-01) ↗ |
| Q2 2022 | Jun 30, 2022 | 74,202 | +1.3% | Form 10-Q (filed 2022-08-02) ↗ |
| Q1 2022 | Mar 31, 2022 | 74,007 | +1.7% | Form 10-Q (filed 2022-05-03) ↗ |
| Q4 2021 | Dec 31, 2021 | 75,196 | +3.6% | Form 10-K (filed 2022-02-18) ↗ |
| Q3 2021 | Sep 30, 2021 | 73,795 | +6.9% | Form 10-Q (filed 2021-11-03) ↗ |
| Q2 2021 | Jun 30, 2021 | 73,269 | +6.5% | Form 10-Q (filed 2021-08-04) ↗ |
| Q1 2021 | Mar 31, 2021 | 72,785 | +9.0% | Form 10-Q (filed 2021-05-05) ↗ |
| Q4 2020 | Dec 31, 2020 | 72,548 | +6.9% | Form 10-K (filed 2021-02-19) ↗ |
| Q3 2020 | Sep 30, 2020 | 69,043 | +0.7% | Form 10-Q (filed 2020-11-04) ↗ |
| Q2 2020 | Jun 30, 2020 | 68,776 | +0.5% | Form 10-Q (filed 2020-07-29) ↗ |
| Q1 2020 | Mar 31, 2020 | 66,777 | -1.2% | Form 10-Q (filed 2020-04-29) ↗ |
| Q4 2019 | Dec 31, 2019 | 67,887 | +1.1% | Form 10-K (filed 2020-02-21) ↗ |
| Q3 2019 | Sep 30, 2019 | 68,539 | -4.3% | Form 10-Q (filed 2019-10-31) ↗ |
| Q2 2019 | Jun 30, 2019 | 68,427 | 0.0% | Form 10-Q (filed 2019-07-31) ↗ |
| Q1 2019 | Mar 31, 2019 | 67,610 | -4.7% | Form 10-Q (filed 2019-05-01) ↗ |
| Q4 2018 | Dec 31, 2018 | 67,173 | -11.9% | Form 10-K (filed 2019-02-22) ↗ |
| Q3 2018 | Sep 30, 2018 | 71,637 | -0.8% | Form 10-Q (filed 2018-10-31) ↗ |
| Q2 2018 | Jun 30, 2018 | 68,415 | -3.8% | Form 10-Q (filed 2018-08-01) ↗ |
| Q1 2018 | Mar 31, 2018 | 70,908 | 0.0% | Form 10-Q (filed 2018-05-02) ↗ |
| Q4 2017 | Dec 31, 2017 | 76,250 | +44.8% | Form 10-K (filed 2018-02-16) ↗ |
| Q3 2017 | Sep 30, 2017 | 72,248 | +82.9% | Form 10-Q (filed 2017-11-02) ↗ |
| Q2 2017 | Jun 30, 2017 | 71,151 | +78.6% | Form 10-Q (filed 2017-08-02) ↗ |
| Q1 2017 | Mar 31, 2017 | 70,887 | +78.8% | Form 10-Q (filed 2017-05-03) ↗ |
| Q4 2016 | Dec 31, 2016 | 52,666 | +27.7% | Form 10-K (filed 2017-02-17) ↗ |
| Q3 2016 | Sep 30, 2016 | 39,497 | -5.3% | Form 10-Q (filed 2016-11-03) ↗ |
| Q2 2016 | Jun 30, 2016 | 39,831 | -9.7% | Form 10-Q (filed 2016-08-03) ↗ |
| Q1 2016 | Mar 31, 2016 | 39,637 | -8.0% | Form 10-Q (filed 2016-05-04) ↗ |
| Q4 2015 | Dec 31, 2015 | 41,247 | +0.1% | Form 10-K (filed 2016-02-19) ↗ |
| Q3 2015 | Sep 30, 2015 | 41,725 | -1.9% | Form 10-Q (filed 2015-11-05) ↗ |
| Q2 2015 | Jun 30, 2015 | 44,125 | +6.4% | Form 10-Q (filed 2015-08-04) ↗ |
| Q1 2015 | Mar 31, 2015 | 43,095 | +3.4% | Form 10-Q (filed 2015-05-06) ↗ |
| Q4 2014 | Dec 31, 2014 | 41,207 | -4.0% | Form 10-K (filed 2016-02-19) ↗ |
| Q3 2014 | Sep 30, 2014 | 42,514 | -3.7% | Form 10-Q (filed 2014-11-06) ↗ |
| Q2 2014 | Jun 30, 2014 | 41,475 | -3.3% | Form 10-Q (filed 2014-08-05) ↗ |
| Q1 2014 | Mar 31, 2014 | 41,662 | -2.4% | Form 10-Q (filed 2014-05-07) ↗ |
| Q4 2013 | Dec 31, 2013 | 42,937 | -36.1% | Form 10-K (filed 2016-02-19) ↗ |
| Q3 2013 | Sep 30, 2013 | 44,132 | -30.2% | Form 10-Q (filed 2013-11-07) ↗ |
| Q2 2013 | Jun 30, 2013 | 42,903 | -30.6% | Form 10-Q (filed 2013-08-06) ↗ |
| Q1 2013 | Mar 31, 2013 | 42,687 | -31.6% | Form 10-Q (filed 2013-05-08) ↗ |
| Q4 2012 | Dec 31, 2012 | 67,235 | +11.5% | Form 10-K (filed 2014-02-21) ↗ |
| Q3 2012 | Sep 30, 2012 | 63,258 | +6.1% | Form 10-Q (filed 2012-11-07) ↗ |
| Q2 2012 | Jun 30, 2012 | 61,860 | -0.2% | Form 10-Q (filed 2012-08-07) ↗ |
| Q1 2012 | Mar 31, 2012 | 62,416 | +1.2% | Form 10-Q (filed 2012-05-08) ↗ |
| Q4 2011 | Dec 31, 2011 | 60,277 | -0.5% | Form 10-K (filed 2014-02-21) ↗ |
| Q3 2011 | Sep 30, 2011 | 59,628 | +3.9% | Form 10-Q (filed 2011-11-04) ↗ |
| Q2 2011 | Jun 30, 2011 | 62,004 | +16.2% | Form 10-Q (filed 2011-08-04) ↗ |
| Q1 2011 | Mar 31, 2011 | 61,651 | +15.5% | Form 10-Q (filed 2011-05-06) ↗ |
| Q4 2010 | Dec 31, 2010 | 60,574 | +15.2% | Form 10-K (filed 2012-02-21) ↗ |
| Q3 2010 | Sep 30, 2010 | 57,374 | +15.1% | Form 10-Q (filed 2010-11-05) ↗ |
| Q2 2010 | Jun 30, 2010 | 53,381 | +12.1% | Form 10-Q (filed 2010-08-05) ↗ |
| Q1 2010 | Mar 31, 2010 | 53,359 | – | Form 10-Q (filed 2010-05-04) ↗ |
| Q4 2009 | Dec 31, 2009 | 52,582 | +24.0% | Form 10-K (filed 2012-02-21) ↗ |
| Q3 2009 | Sep 30, 2009 | 49,847 | – | Form 10-Q (filed 2009-11-06) ↗ |
| Q2 2009 | Jun 30, 2009 | 47,630 | – | Form 10-Q (filed 2009-08-07) ↗ |
| Q4 2008 | Dec 31, 2008 | 42,419 | +6.8% | Form 10-Q (filed 2009-08-07) ↗ |
| Q4 2007 | Dec 31, 2007 | 39,714 | – | Form 10-K (filed 2010-02-19) ↗ |
Breakdown
What makes up total assets ($m)
- Cash & Cash Equivalents ($M)5,104 · Q2 2026
- Short-Term Investments ($M)499 · Q2 2026
- Trade Accounts Receivable, Net ($M)8,599 · Q2 2026
- Total Inventories ($M)7,315 · Q2 2026
- Total Current Assets ($M)24,517 · Q2 2026
- Net Property & Equipment ($M)12,812 · Q2 2026
- Goodwill ($M)35,244 · Q2 2026
- Intangible Assets, Net of Amortization ($M)17,211 · Q2 2026
- Total Current Liabilities ($M)17,814 · Q2 2026
- Long-Term Debt ($M)29,603 · Q2 2026
- Total Shareholders' Investment / Equity ($M)51,110 · Q2 2026
Cite this data
StockData. (2026). Abbott Laboratories Total Assets ($M) ($M), quarterly Q4 2007–Q2 2026 [Data set]. Compiled from Abbott Laboratories SEC filings and investor materials. https://stockdatahq.com/stocks/abt/kpis/db-bs-assets
See every metric in the Abbott Laboratories KPI table. Data updated Oct 29, 2026.